Portal de Periódicos da CAPES

Clinical evaluation of l-asparaginase.Introduction

1970; Wiley; Volume: 25; Issue: 2 Linguagem: Inglês

10.1002/1097-0142(197002)25

1097-0142

Joseph H. Burchenal, David A. Karnofsky,

Childhood Cancer Survivors' Quality of Life

CancerVolume 25, Issue 2 p. 241-243 ArticleFree Access Clinical evaluation of l-asparaginase. Introduction Joseph H. Burchenal MD, Joseph H. Burchenal MDSearch for more papers by this authorDavid A. Karnofsky MD, David A. Karnofsky MDSearch for more papers by this author Joseph H. Burchenal MD, Joseph H. Burchenal MDSearch for more papers by this authorDavid A. Karnofsky MD, David A. Karnofsky MDSearch for more papers by this author First published: February 1970 https://doi.org/10.1002/1097-0142(197002)25:2 3.0.CO;2-6Citations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Adamson, R. H., and Fabro, S.: Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)—a review. Cancer Chemother. Rep. 52: 617– 626, 1968. 2 Boyse, E. A., Old, L. J., Campbell, H. A., and Mashburn, L. T.: Suppression of murine leukemias by L-asparaginase. Incidence of sensitivity among leukemias of various types: comparative inhibitory activities of guinea pig serum L-asparaginase and Escherichia coli L-asparaginase. J. Exp. Med. 125: 17– 31, 1967. 3 Broome, J. D.: Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. Nature 191: 1114– 1115, 1961. 4 Broome, J. D.: Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance. J. Exp. Med. 118: 99– 120, 1963. 5 Broome, J. D., Burchenal, J. H.: Clinical evaluation and future prospects of asparaginase. Proceedings of the Plenary Session of the European Organization for Research on Treatment of Cancer (Paris, 1969), In press. 6 Broome, J. D., Success and failure in present chemotherapy and the implications of asparaginase. Proceedings of the ACS-UICC Conference, “A Critical Evaluation of Cancer Chemotherapy” (Cherry Hill, N.J., 1969), Cancer Res. (In press). 7 Broome, J. D., and Dollinger, M. R.: Cytosine arabinoside (NSC-63878) in combination with 6-mercaptopurine (NSC-755), methotrexate (NSC-740), or fluorouracil (NSC-19893) in L1210 mouse leukemia. Cancer Chemother. Rep. 51: 435– 438, 1967. 8 Broome, J. D., Lash, E., Schwartz, M., and Dollinger, M.: Effects and concentrations of L-asparaginase in intracerebrally inoculated leukemia. Proc. Amer. Ass. Cancer Res. 9: 10, 1968. 9 Clarkson, B., Krakoff, I., Burchenal, J., Karnofsky, D., Golbey, R., Oettgen, H., Dowling, M., and Lipton, A.: Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors. Cancer 25: 279– 305, 1970. 10 Clementi, A.: Desamidation enzymatique de L'asparagine. Arch. Int. Physiol. 19: 369– 398, 1922. 11 DeBarros, T., Filho, M. C., DeSantana, C. F., Valenca, M., DaSilva, M. P., Guedes, J., and DeCarvalho, A. R. L.: Utilizacao de L-asparaginase em paciente humano portador de neoplasia maligna. Anais da Faculdade de Medicina da Universidade do Recife 25: 21– 28, 1965. 12 Dollinger, M. R., Benvenisti, D., Kaufman, M., and Burchenal, J. H.: Effect of L-asparaginase (A-ase) on asparagine dependent mouse leukemic cells in culture. Proc. Amer. Ass. Cancer Res. 10: 20, 1969. 13 Dolowy, W. C., Cornet, J., Henson, D., and Ammeraal, R.: Response of intracerebral Gardner lymphoma to guinea pig L-asparaginase and Escherichia coli L-asparaginase. Proc. Soc. Exp. Biol. Med. 123: 132– 137, 1966. 14 Dolowy, W. C., Henson, D., Cornet, J., and Sellin, H.: Toxic and antineoplastic effects of L-asparaginase. Cancer 19: 1813– 1819, 1966. 15 Fisher, G. A.: Studies of the culture of leukemic cells in vitro. Ann. N.Y. Acad. Sci. 76: 673– 680, 1958. 16 Gee, T. S., Yu, K. P., Augustin, B. T., Krakoff, I. H., and Clarkson, B. D.: Combination therapy of adult acute leukemia with thioguanine (TG) and 1-β-D-arabinofuranosylcytosine (CA). Proc. Amer. Ass. Cancer Res. 9: 23, 1968. 17 Gee, T. S., Yu, K. P., and Clarkson, B. D.: Treatment of adult acute leukemia with arabinosylcytosine and thioguanine. Cancer 23: 1019– 1032, 1969. 18 Haley, E. E., Fischer, G. A., and Welch, A. D.: The requirement for L-asparagine of mouse leukemia cells L5178Y in culture. Cancer Res. 21: 532– 536, 1961. 19 Hill, J. M., Roberts, J., Loeb, E., Khan, A., MacLellan, A., and Hill, R. W.: L-asparaginase therapy for leukemia and other malignant neoplasms. JAMA 202: 882– 888, 1967. 20 Karnofsky, D. A.: Personal communication. 21 Kidd, J. G.: Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum. J. Exp. Med. 98: 565– 581, 1953. 22 Mashburn, L. T., and Wriston, J. C.: Tumor inhibitory effect of L-asparaginase from Escherichia coli. Arch. Biochem. Biophys. 105: 450– 452, 1964. 23 Neuman, R. E., and McCoy, T. A.: Dual requirement of Walker carcinosarcoma 256 in vitro for asparagine and glutamine. Science 124: 124– 125, 1956. 24 Oettgen, H. F., Old, L. J., Boyse, E. A., Campbell, H. A., Philips, F. S., Clarkson, B. D., Tallal, L., Leeper, R. D., Schwartz, M. K., and Kim, J. H.: Inhibition of leukemias in man by L-asparaginase. Cancer Res. 27: 2619– 2631, 1967. 25 Oettgen, H. F., Stephenson, P. A., Schwartz, M. K., Leeper, R. D., Tallal, L., Tan, C. C., Clarkson, B. D., Golbey, R. B., Krakoff, I. H., Karnofsky, D. A., Murphy, M. L., and Burchenal, J. H.: The toxicity of E. coli L-asparaginase in man. Cancer 25: 253– 278, 1970. 26 Old, L. J., Boyse, E. A., Campbell, H. A., and Daria, G. M.: Leukaemia-inhibiting properties and L-asparaginase activity in sera from certain South American rodents. Nature 198: 801, 1963. 27 Old, L. J., Boyse, E. A., Campbell, H. A., Brodey, R. S., Fidler, J., and Teller, J. D.: Treatment of lymphosarcoma in the dog with L-asparaginase. Cancer 20: 1066– 1070, 1967. 28 Schwartz, M. K., Lash, E. D., Octtgen, H. F., and Toma, F. A.: L-asparaginase activity in plasma and other biological fluids. Cancer 25: 244– 252, 1970. 29 Tallal, L., Tan, C., Oettgen, H., Wollner, N., McCarthy, M., Helson, L., Burchenal, J., Karnofsky, D., and Murphy, M. L.: E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children. Cancer 25: 306– 320. Citing Literature Volume25, Issue2February 1970Pages 241-243 ReferencesRelatedInformation